This enduring activity aims to strengthen clinicians ability to integrate the latest anti-amyloid therapy advances, including maintenance strategies and long-term evidence, into real-world care for patients with early Alzheimer s disease. Learners have access to downloadable slides for future use in practice.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 27 Trinity Place, Suite 185
Pricing
99% of listed courses are free
152 of 153 courses listed here are free.
Collected from the provider’s public pages
Specialties served/covered
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General Internal Medicine
- General Pediatrics
- General Surgery
- Gynecologic Oncology
- Hematology
- Infectious Disease
- Interventional Cardiology
- Maternal-Fetal Medicine
- Medical Oncology
- Nephrology
- Neurocritical Care
- Neurology
- Neuromuscular Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pediatric Gastroenterology
- Pediatric Infectious Diseases
- Pulmonary Disease
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Transplant Hepatology
- Urological Oncology
- Urology
- Vascular Neurology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pathology & Lab
- Pediatrics
- Primary care
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Microlearning
- Credit · Up to 0.5 credits
- MOC · Up to 0.5 points
- Commercial Support
-
ReleasedSep 9, 2026
-
Last day to claim creditSep 9, 2027 11 months left
-
Answers in CME Inc. (AiCME) From Symptoms to Stability: Emerging OX40/OX40L-Targeted Therapies, Durable AD Control, and Enhanced Quality of Life
-
Answers in CME Inc. (AiCME) Bridging Clinical Trial and Real-World Evidence in Retinal Diseases: Updated Strategies With Anti-VEGF Therapies
-
Answers in CME Inc. (AiCME) Navigating the Later-Line mCRC Journey: Optimizng Treatment Sequencing and Long-Term Outcomes
-
Alzheimer's Association +1 ISTAART Voices Season 1 – Decoding Alzheimer’s: Using Algorithms To Predict Cognitive Decline
-
Metabolic Mind +1 The Evidence Supporting Ketogenic Therapy for the Treatment of Serious Mental Illness
-
Medscape, LLC Medscape Now! Clinical Frameworks for Treatment Planning: Optimizing Timing, Duration, and Monitoring Across Healthcare Teams
